Skip to content

ABOUT US
OUR SCIENCE
OUR PRODUCTS
OUR PIPELINE
OUR PUBLICATIONS
OUR TRIALS
- TRIAL INFORMATION
- EXPANDED ACCESS POLICY
INVESTORS & MEDIA

ABOUT US
OUR SCIENCE
OUR PRODUCTS
OUR PIPELINE
OUR PUBLICATIONS
OUR TRIALS
- TRIAL INFORMATION
- EXPANDED ACCESS POLICY
INVESTORS & MEDIA

https://www.tgtherapeutics.com/wp-content/uploads/2026/03/Hartung-HP_Neuro-Ther-2026-3.6.26.pdf

Efficacy of Ublituximab in People with Highly Active Relapsing Multiple Sclerosis

By Sheena Cruz / 03/09/2026

X-twitter Linkedin

JOIN US
CONTACT US
EXPANDED ACCESS POLICY
PRIVACY POLICY
TERMS OF USE

© 2026 TG Therapeutics, Inc. All rights reserved.
Website by Tidal Media Group

Scroll to Top